Irritable Bowel Syndrome News

By the time a patient with irritable bowel syndrome gets to a tertiary referral physician like me, they have likely tried a lot of treatments.

In my clinic, it still feels like we get countless referrals for irritable bowel syndrome.

More than 30 million people in the United States have irritable bowel syndrome.

CHICAGO — Measuring vagal efficiency through respiratory sinus arrythmia in patients with functional abdominal pain could help predict therapeutic response to percutaneous electrical nerve field stimulation, according to research presented at the NASPGHAN Annual Meeting.

A non-invasive device that delivers neurostimulation to the external ear reduced pain scores and improved overall well-being in children with irritable bowel syndrome, according to study results.

SAN ANTONIO — Healio will host its second Disruptive Innovators reception during the American College of Gastroenterology’s Annual Scientific Meeting (ACG 2019) on October 27, 2019, at the Grand Hyatt San Antonio.

The American Gastroenterological Association released new clinical practice guidelines for the evaluation of chronic diarrhea.

Healio Gastroenterology and Liver Disease has compiled a list of some of the most recent approvals and updates from the FDA.

The FDA on Thursday approved Ibsrela, a 50 mg, twice-daily oral therapy for irritable bowel syndrome with constipation in adults.

Recently published studies have demonstrated new developments in diarrhea- and constipation-predominant irritable bowel syndrome, as well as peppermint oil as a treatment for the condition.